Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Chen, Jun ^a   Chia, Nicholas ^a   Kalari, Krishna R ^a   Yao, Janet Z ^a   Novotna, Martina ^a,b   Soldan, M Mateo Paz ^a   Luckey, David H ^c   Marietta, Eric V ^a   Jeraldo, Patricio R ^a   Chen, Xianfeng ^a   Weinshenker, Brian G ^a   Rodriguez, Moses ^a,c   Kantarci, Orhun H ^a   Nelson, Heidi ^a,c   Murray, Joseph A ^c   Mangalam, Ashutosh K ^c,d  

^a MAYO CLINIC   (United States)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c MAYO GRADUATE SCHOOL   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

ADULT; DYSBIOSIS; FEMALE; GASTROINTESTINAL TRACT; GENETICS; HUMAN; INTESTINE FLORA; MALE; MICROBIOLOGY; MICROFLORA; MULTIPLE SCLEROSIS;

ADULT; DYSBIOSIS; FEMALE; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; MALE; MICROBIOTA; MULTIPLE SCLEROSIS; RNA, RIBOSOMAL, 16S;

EID: 84976536578     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep28484     Document Type: Article

References (33)

1. Sospedra, M. & Martin, R. Immunology of multiple sclerosis. Annu Rev Immunol 23, 683-747 (2005).
2. Ascherio, A. Environmental factors in multiple sclerosis. Expert Rev Neurother 13, 3-9 (2013).
3. Oksenberg, J. R. Decoding multiple sclerosis: An update on genomics and future directions. Expert Rev Neurother 13, 11-19 (2013).
4. Fleming, J. & Fabry, Z. The hygiene hypothesis and multiple sclerosis. Annals of neurology 61, 85-89 (2007).
5. Rook, G. A. Hygiene hypothesis and autoimmune diseases. Clinical reviews in allergy & immunology 42, 5-15 (2012).
6. Nusrat, S., Gulick, E., Levinthal, D. & Bielefeldt, K. Anorectal dysfunction in multiple sclerosis: A systematic review. ISRN neurology 2012, 376023 (2012).
7. Yacyshyn, B., Meddings, J., Sadowski, D. & Bowen-Yacyshyn, M. B. Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeability. Digestive diseases and sciences 41, 2493-2498 (1996).
8. Gupta, G., Gelfand, J. M. & Lewis, J. D. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology 129, 819-826 (2005).
9. Kimura, K. et al. Concurrence of inflammatory bowel disease and multiple sclerosis. Mayo Clinic proceedings 75, 802-806 (2000).
10. Braniste, V. et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med 6, 263ra158 (2014).
11. Jeraldo, P. et al. IM-TORNADO: A Tool for Comparison of 16S Reads from Paired-End Libraries. PLoS One 9, e114804 (2014).
12. Miyake, S. et al. Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters. PLoS One 10, e0137429 (2015).
13. Cantarel, B. L. et al. Gut microbiota in multiple sclerosis: possible influence of immunomodulators. J Investig Med 63, 729-734 (2015).
14. Walters, W. A., Xu, Z. & Knight, R. Meta-Analyses of human gut microbes associated with obesity and IBD. FEBS Lett 588, 4223-4233 (2014).
15. Korkina, L., Kostyuk, V., De Luca, C. & Pastore, S. Plant phenylpropanoids as emerging anti-inflammatory agents. Mini Rev Med Chem 11, 823-835 (2011).
16. Schogor, A. L. et al. Ruminal Prevotella spp. may play an important role in the conversion of plant lignans into human health beneficial antioxidants. PLoS One 9, e87949 (2014).
17. Toh, H., Oshima, K., Suzuki, T., Hattori, M. & Morita, H. Complete Genome Sequence of the Equol-Producing Bacterium Adlercreutzia equolifaciens DSM 19450T. Genome announcements 1 (2013).
18. Moussa, L. et al. A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease. PLoS One 7, e49547 (2012).
19. Confavreux, C., Hutchinson, M., Hours, M. M., Cortinovis-Tourniaire, P. & Moreau, T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. The New England journal of medicine 339, 285-291 (1998).
20. Moore, S. M. et al. Multiple functional therapeutic effects of the estrogen receptor beta agonist indazole-Cl in a mouse model of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America 111, 18061-18066 (2014).
21. Spence, R. D. & Voskuhl, R. R. Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. Frontiers in neuroendocrinology 33, 105-115 (2012).
22. Labbe, A., Ganopolsky, J. G., Martoni, C. J., Prakash, S. & Jones, M. L. Bacterial bile metabolising gene abundance in Crohn's, ulcerative colitis and type 2 diabetes metagenomes. PLoS One 9, e115175 (2014).
23. Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E. & Fiorucci, S. The bile acid receptor FXR is a modulator of intestinal innate immunity. J Immunol 183, 6251-6261 (2009).
24. Gevers, D. et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell host & microbe 15, 382-392 (2014).
25. Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341 (2011).
26. Kang, D. W. et al. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One 8, e68322 (2013).
27. Murri, M. et al. Gut microbiota in children with type 1 diabetes differs from that in healthy children: A case-control study. BMC medicine 11, 46 (2013).
28. Mukhopadhya, I., Hansen, R., El-Omar, E. M. & Hold, G. L. IBD-what role do Proteobacteria play? Nature reviews. Gastroenterology & hepatology 9, 219-230 (2012).
29. Jenq, R. R. et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med 209, 903-911 (2012).
30. Bajaj, J. S. et al. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. American journal of physiology. Gastrointestinal and liver physiology 303, G675-685 (2012).
31. Salter, S. J. et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC biology 12, 87 (2014).
32. McDonald, W. I. et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of neurology 50, 121-127 (2001).
33. Langille, M. G. et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nature biotechnology 31, 814-821 (2013).